Real-world experience with the IUB Ballerine MIDI copper IUD: an observational, single-centre study in Israel

被引:3
|
作者
Baram, Ilan [1 ,2 ]
Aharon, Arnon [2 ]
Klein, Rinat [2 ]
Shkolnik, Ketty [2 ]
机构
[1] Maccabi Healthcare Serv, Modiin, Israel
[2] OCON Healthcare, Clin Dev, Modiin, Israel
关键词
Contraceptive; IUB; IUB Ballerine MIDI; IUD; LARC; UNINTENDED PREGNANCY; CONTRACEPTIVE METHODS; INTRAUTERINE-DEVICE; UNITED-STATES; EFFICACY;
D O I
10.1080/13625187.2019.1699048
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: The aim of the study was to assess the acceptability of the intrauterine ball IUB Ballerine MIDI copper intrauterine device (IUD), using real-world data collected from users and physicians in Israel. Methods: In this retrospective, observational study, conducted in a single clinic in Israel, healthy women (n = 175) who had had the device inserted >= 12 months prior to enrolment, and their physician, completed questionnaires relating to device insertion, user experience and performance. Results: The mean age at insertion was 32.8 +/- 6.7 years; most women were married (80.6%) and multigravid (89.1%). At the time of the study, 131 (74.9%) women were still using the device; in 13 cases (7.4%), premature removal was due to desire to conceive. The 12 month continuation rate, excluding the women seeking to conceive, was 90.1%. The expulsion rate was 3.4% (n = 6) and the pregnancy rate was 0.57% (n = 1). Most of the women still using the device reported no to moderate pain or cramps (90.0%) and moderate to high (72.6%) satisfaction with the device; 76.3% said they would recommend it to friends and relatives. Most of the insertion procedures (86.9%) were uneventful and none required cervical dilation. Conclusion: The IUB Ballerine MIDI raised no major safety concerns and was both effective and highly accepted in a cohort of women, covering a broad age range, treated in a gynaecology clinic in Israel.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 50 条
  • [31] Upadacitinib real-world efficacy and safety in treatment of inflammatory bowel disease: an Australian single-centre experience
    Chen, Gordon
    Rao, Vikram
    Lo, Sheng Wei
    Koh, Elaine
    Kaul, Abha
    La Nauze, Richard
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 278 - 279
  • [32] Clinical role of PRAME expression in melanocytic tumours: A single-centre real-world retrospective study
    Hidalgo, Leonel
    Peirano, Dominga
    Donoso, Francisca
    Villagran, Sofia
    Carrasco, Karina
    Rossi, Anthony M.
    Villarroel, Alejandra
    Del Puerto, Constanza
    Villaseca-Hernandez, Miguel
    Navarrete-Dechent, Cristian
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (10) : E1245 - E1247
  • [33] Tuberculosis infection in Chinese patients with psoriasis treated with secukinumab: a single-centre real-world study
    Xiao, Y.
    Li, G.
    Wang, Y.
    Gu, Y.
    Wang, J.
    Li, W.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E38 - E39
  • [34] The Real-World Experience of the Biosimilar (Grastofil®) to the Reference Biologic (Neupogen®) in Breast Cancer and Lymphoma: A Canadian Single-Centre Retrospective Study
    Wong, Gina
    Wang, Katie
    Pasetka, Mark
    Zhang, Liying
    Lou, Julia
    Majeed, Habeeb
    Flores, Jerome
    Lam, Emily
    DeAngelis, Carlo
    CURRENT ONCOLOGY, 2022, 29 (03) : 1349 - 1369
  • [35] Real-world outcomes of children treated with dupilumab for moderate-to-severe atopic dermatitis: a single-centre retrospective observational UK study
    Hosseini-Ashrafi, Mozhgan
    Clayton, Tim H.
    Herring, Michelle
    Herety, Nichola
    Arkwright, Peter D.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (06) : 578 - 583
  • [36] Switching to Biktarvy: real-world single-centre outcomes over 3 years
    King, Lisa
    Mackie, Nicola
    Foster, Caroline
    HIV MEDICINE, 2023, 24 : 26 - 26
  • [37] Real-world outcomes of Voretigene Neparvovec: a single-centre consecutive case series
    Jalil, Assad
    Ferrara, Mariantonia
    Lippera, Myrta
    Parry, Neil
    Black, Graeme C.
    Banderas, Sandra
    Ashworth, Jane
    Biswas, Sus
    Hall, Georgina
    Gray, Jane
    Newman, William
    Ivanova, Tsveta
    EYE, 2025, : 1356 - 1363
  • [38] Real-world experience of dacomitinib in mEGFR Advanced NSCLC: A single centre experience
    Biswas, B.
    Ganguly, S.
    Ghosh, J.
    Roy, S.
    Bhattacharjee, A.
    Bakshi, R.
    ANNALS OF ONCOLOGY, 2023, 34
  • [39] Real-world outcomes of long-term use of silexan in patients with anxiety disorders: a single-centre experience
    Marchevsky, Sergio
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2024,
  • [40] Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experience
    Bimbatti, Davide
    Dionese, Michele
    Lai, Eleonora
    Cavasin, Nicolo
    Basso, Umberto
    Mattana, Alvise
    Pierantoni, Francesco
    Zagonel, Vittorina
    Maruzzo, Marco
    FRONTIERS IN ONCOLOGY, 2022, 12